Form4insider filings, from the source

SEC Form 4 · accession 0001144204-18-002648

OPIANT PHARMACEUTICALS, INC. · OPNT

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Geoffrey Wolf
10% Owner
Period of report
Dec 14, 2017
Accepted (ET)
Jan 18, 2018 · 3:48 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001385508

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1Dec 19, 2017C37,860$15.00A111,497D
Common StockDec 14, 2017C20,000$15.00A131,497D
Common StockDec 19, 2017S3,850$19.69D127,647D
Common stockDec 20, 2017S69,016$22.75D57,850D
Common StockDec 21, 2017S20,000$24.17D37,850D
Common StockDec 21, 2017C109,000$15.00A146,850D
Common stockDec 22, 2017C32,000$15.00A178,850D
Common StockDec 27, 2017S37,850$21.51D141,000D
Common StockDec 28, 2017S43,000$22.52D98,000D
Common stockDec 28, 2017C116,150$15.00A214,150D

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
WarrantsF2$15.00Dec 19, 2017C37,860ASep 1, 2017Dec 31, 2017Common Stock37,860203,010D
Warrants$15.00Dec 14, 2017C20,000ASep 1, 2017Dec 31, 2017Common Stock20,000168,160D
Warrants$15.00Dec 21, 2017C109,000ASep 1, 2017Dec 31, 2017Common Stock109,000148,150D
Warrants$15.00Dec 22, 2017C32,000ASep 1, 2017Dec 31, 2017Common Stock32,000116,150D
Warrants$15.00Dec 28, 2017C116,150ASep 1, 2017Dec 31, 2017Common Stock116,1500D

Explanation of responses